预防轻度血友病A关节出血所需的最低凝血因子VIII水平
这项回顾性研究纳入270例在米兰Angelo Bianchi Bonomi血友病与血栓中心随访的先天性轻度血友病A男性患者,中位年龄45岁,终生中位FVIII为21 IU/dL。调整年龄后,FVIII每升高1 IU/dL,年化关节出血率降低6%,自发性年化关节出血率降低11%;预防终生任何关节出血和自发性关节出血的最低FVIII水平分别为19.2 IU/dL和17.7 IU/dL。
要点
- 270例轻度血友病A患者中,100例(37%)有终生至少1次关节出血史。
- 调整年龄后,FVIII每升高1 IU/dL,年化关节出血率降低6%,自发性年化关节出血率降低11%。
- 预防终生任何关节出血和自发性关节出血的最低FVIII水平分别为19.2 IU/dL和17.7 IU/dL。
核心结论
- 在这大队列轻度血友病A患者中,确定了预防任何关节出血和自发性关节出血所需的最低FVIII水平分别为19.2 IU/dL和17.7 IU/dL。
- 这些发现可能对中度至重度血友病A患者预防治疗的准确设计(包括基因治疗)有重要意义。
研究设计与样本
- 回顾性研究,纳入在米兰Angelo Bianchi Bonomi血友病与血栓中心随访的先天性轻度血友病A患者。
- 纳入标准为按需治疗、年龄≥16岁、无FVIII抑制物史。
- 共纳入270例男性患者,中位年龄45岁(范围16-88岁),终生中位FVIII为21 IU/dL。
主要发现
- 100例患者(37%)有终生至少1次关节出血史。
- 平均年化关节出血率(AJBR)为0.016(标准差0.032),自发性AJBR为0.001(标准差0.010)。
- 调整年龄后,FVIII每升高1 IU/dL,AJBR降低6%,自发性AJBR降低11%。
- 预防终生任何关节出血所需的最低FVIII水平为19.2 IU/dL,预防自发性关节出血所需的最低FVIII水平为17.7 IU/dL。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The severity of the bleeding phenotype in patients with hemophilia A (HA) broadly correlates with the degree of coagulation factor VIII (FVIII) deficiency in plasma. However, the FVIII level necessary to achieve the goal of zero joint bleeds remains unclear. This study aimed to identify the minimum FVIII level necessary to prevent joint bleeds in patients with HA. In this retrospective study, patients with congenital mild HA treated on demand, aged ≥16 years, with no history of FVIII inhibitors, followed at the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center in Milan, were enrolled. We investigated 270 male patients with a median age of 45 years (16-88) and median lifelong FVIII of 21 IU/dL. One hundred patients (37%) had a lifelong history of at least 1 joint bleed. The mean annualized joint bleeding rate (AJBR) and spontaneous AJBR were 0.016 (standard deviation [SD], 0.032) and 0.001 (SD, 0.010), respectively. After adjusting for age, for each IU/dL increase in FVIII, there was a 6% reduction in AJBR and an 11% reduction in spontaneous AJBR. The minimum FVIII levels needed to prevent lifelong any joint bleeds and spontaneous joint bleeds resulted to be 19.2 IU/dL and 17.7 IU/dL, respectively. In this large cohort of persons with mild HA, we identified the minimum FVIII levels needed to prevent total and spontaneous joint bleeds (19.2 IU/dL and 17.7 IU/dL, respectively). These findings could suggest important implications for the accurate design of prophylactic therapies for persons with moderate and severe HA, including gene therapy.
引用
- Agosti P, Siboni SM, Scardo S, et al. Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A. Blood Adv. 2023. PMID: 37871302. doi:10.1182/bloodadvances.2023011366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。